Dan Oren's Net Worth
$0
Estimate Recalculated Nov 5, 2024 05:01PM EST
Who is Dan Oren?
Dan Oren does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Roivant Sciences Ltd., Arbutus Biopharma Corp, Myovant Sciences Ltd., Urovant Sciences Ltd., Axovant Sciences Ltd., Intec Pharma Ltd., and Protalix BioTherapeutics, Inc..
SEC CIK
Dan Oren's CIK is 0001636701
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Roivant Sciences Ltd. (ROIV) Snapshot price: $12.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.05% | 4M |
$5.00 | $20,000,000.00 | 102.85M |
Nov 10
| |||
Form 4
| +0.04% | 40.28K |
$3.85 | $154,954.16 | 98.85M |
Apr 22 - Apr 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arbutus Biopharma Corp (ABUS) Snapshot price: $4.5488
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Myovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +6.32% | 2.42M |
$8.25 | $19,999,996.50 | 40.77M |
Jun 4
| |||
Form 4
| +2.98% | 1.11M |
$20.27 | $22,500,004.05 | 38.34M |
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Intec Pharma Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -17.78% | -915.95K |
$0.31 | -$281,658.86 | 4.23M |
Jan 31 - Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Urovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +0.04% | 18.2K |
$8.36 | $151,380.99 | 45.71M |
Scheduled
|
Jun 17 - Jun 19
| ||
Form 4
| +0.05% | 22.01K |
$8.12 | $177,300.64 | 45.67M |
Scheduled
|
Jun 12 - Jun 14
| ||
Form 4
| +0.05% | 21.34K |
$8.22 | $177,247.38 | 45.62M |
Scheduled
|
Jun 7 - Jun 11
| ||
Form 4
| +0.05% | 21.12K |
$7.80 | $165,950.15 | 45.58M |
Scheduled
|
Jun 4 - Jun 6
| ||
Form 4
| +0.04% | 17.75K |
$7.86 | $138,946.36 | 45.54M |
Scheduled
|
May 30 - Jun 3
| ||
Form 4
| +0.03% | 14.48K |
$7.65 | $110,461.18 | 45.51M |
Scheduled
|
May 24 - May 29
| ||
Form 4
| +0.02% | 9.84K |
$7.91 | $77,809.93 | 45.49M |
Scheduled
|
May 22 - May 23
| ||
Form 4
| +0.04% | 9.99K |
$8.52 | $85,108.42 | 22.74M |
May 21
| |||
Form 4
| +0.02% | 10K |
$8.19 | $80,524.83 | 45.45M |
May 20
| |||
Form 4
| +0.03% | 11.61K |
$7.08 | $82,359.46 | 45.42M |
May 16 - May 17
| |||
Form 4
| +13.38% | 2.68M |
$14.00 | $37,499,994.00 | 22.7M |
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||